Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Progyny: Transitional Headwinds Hide An Undervalued Platform
11:13am, Wednesday, 04'th Mar 2026
Progyny (PGNY) is undervalued at 9.3x forward P/E, with strong cash flow, expanding margins, and a resilient business model post-Amazon client loss. Headline FY26 growth appears muted (5.1%–9%) due
Progyny, Inc. (PGNY) Q4 2025 Earnings Call Transcript
08:17pm, Thursday, 26'th Feb 2026
Progyny, Inc. (PGNY) Q4 2025 Earnings Call Transcript
Progyny (PGNY) Q4 Earnings and Revenues Surpass Estimates
07:46pm, Thursday, 26'th Feb 2026
Progyny (PGNY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.42 per share a year ago.
Compared to Estimates, Progyny (PGNY) Q4 Earnings: A Look at Key Metrics
07:30pm, Thursday, 26'th Feb 2026
The headline numbers for Progyny (PGNY) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Progyny, Inc. Announces Fourth Quarter 2025 Results
04:01pm, Thursday, 26'th Feb 2026
Reports Revenue of $318.4 Million, Reflecting Fourth Quarter Growth of 6.7% and 10% for the Full YearGenerated Record $210.2 Million in Full Year Operating Cash FlowReturned Value to Shareholders Thro
Seeking Clues to Progyny (PGNY) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:15am, Wednesday, 25'th Feb 2026
Besides Wall Street's top-and-bottom-line estimates for Progyny (PGNY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report
02:46pm, Thursday, 12'th Feb 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period an
Contrasting Amarantus Bioscience (OTCMKTS:AMBS) & Progyny (NASDAQ:PGNY)
01:08am, Monday, 09'th Feb 2026
Progyny (NASDAQ: PGNY - Get Free Report) and Amarantus Bioscience (OTCMKTS:AMBS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies bas
105,000 Shares in Progyny, Inc. $PGNY Acquired by Hussman Strategic Advisors Inc.
06:00am, Wednesday, 28'th Jan 2026
Hussman Strategic Advisors Inc. acquired a new stake in Progyny, Inc. (NASDAQ: PGNY) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acq
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
02:25pm, Tuesday, 13'th Jan 2026
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
08:00am, Monday, 12'th Jan 2026
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced that the
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out?
10:15am, Friday, 09'th Jan 2026
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
3 Medical Service Industry Stocks Set to Tackle Workforce Challenges
10:06am, Friday, 09'th Jan 2026
Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.
Pacer Advisors Inc. Has $8.29 Million Stock Holdings in Progyny, Inc. $PGNY
05:50am, Monday, 29'th Dec 2025
Pacer Advisors Inc. reduced its holdings in Progyny, Inc. (NASDAQ: PGNY) by 28.5% in the undefined quarter, according to the company in its most recent filing with the SEC. The firm owned 385,079 shar
Zicix (OTCMKTS:ZICXD) vs. Progyny (NASDAQ:PGNY) Head-To-Head Survey
01:47am, Thursday, 25'th Dec 2025
Progyny (NASDAQ: PGNY - Get Free Report) and Zicix (OTCMKTS:ZICXD - Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses based on the str
